Alterity Therapeutics Ltd (ATHE)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
Nov 14, 16:00
1.16
-0.01
(-0.85%)
After-Hours: 19:53
Alterity Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.869M |
| November 12, 2024 | 1.694M |
| November 11, 2024 | 1.956M |
| November 08, 2024 | 1.694M |
| November 07, 2024 | 1.869M |
| November 06, 2024 | 2.215M |
| November 05, 2024 | 1.907M |
| November 04, 2024 | 1.520M |
| November 01, 2024 | 1.781M |
| October 31, 2024 | 1.606M |
| October 30, 2024 | 1.832M |
| October 29, 2024 | 1.652M |
| October 28, 2024 | 1.606M |
| October 25, 2024 | 1.694M |
| October 24, 2024 | 1.799M |
| October 23, 2024 | 1.780M |
| October 22, 2024 | 2.044M |
| October 21, 2024 | 2.218M |
| October 18, 2024 | 2.568M |
| October 17, 2024 | 2.044M |
| October 16, 2024 | 2.481M |
| October 15, 2024 | 2.566M |
| October 14, 2024 | 2.481M |
| October 11, 2024 | 2.787M |
| October 10, 2024 | 2.743M |
| Date | Value |
|---|---|
| October 09, 2024 | 3.005M |
| October 08, 2024 | 3.180M |
| October 07, 2024 | 2.918M |
| October 04, 2024 | 3.792M |
| October 03, 2024 | 4.229M |
| October 02, 2024 | 4.054M |
| October 01, 2024 | 3.574M |
| September 30, 2024 | 3.027M |
| September 27, 2024 | 3.136M |
| September 26, 2024 | 2.393M |
| September 25, 2024 | 2.529M |
| September 24, 2024 | 2.680M |
| September 23, 2024 | 2.548M |
| September 20, 2024 | 2.459M |
| September 19, 2024 | 2.282M |
| September 18, 2024 | 2.193M |
| September 17, 2024 | 2.946M |
| September 16, 2024 | 3.080M |
| September 13, 2024 | 2.725M |
| September 12, 2024 | 2.725M |
| September 11, 2024 | 3.168M |
| September 10, 2024 | 2.725M |
| September 09, 2024 | 3.100M |
| September 06, 2024 | 2.548M |
| September 05, 2024 | 2.725M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.11M
Minimum
Dec 28 2022
59.91M
Maximum
Jul 08 2021
9.030M
Average
3.080M
Median
Aug 07 2024
Enterprise Value Benchmarks
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 544.62M |
| Mesoblast Ltd | -- |
| Immuron Ltd | 3.484M |